These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 16287915)
1. Ex vivo CD(+) T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation. Koarada S; Haruta Y; Mitamura M; Morito F; Tada Y; Ohta A; Nagasawa K Rheumatology (Oxford); 2006 Apr; 45(4):392-9. PubMed ID: 16287915 [TBL] [Abstract][Full Text] [Related]
2. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease. Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429 [TBL] [Abstract][Full Text] [Related]
3. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines. Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433 [TBL] [Abstract][Full Text] [Related]
5. Cytokine profile of t lymphocytes from peripheral blood and bronchoalveolar lavage fluid in patients with active pulmonary tuberculosis. Boras Z; Juretić A; Gagro A; Pavelić Lj Scand J Immunol; 2007 Mar; 65(3):257-64. PubMed ID: 17309780 [TBL] [Abstract][Full Text] [Related]
6. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. Inui N; Chida K; Suda T; Nakamura H J Allergy Clin Immunol; 2001 Feb; 107(2):337-44. PubMed ID: 11174202 [TBL] [Abstract][Full Text] [Related]
7. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b. Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198 [TBL] [Abstract][Full Text] [Related]
8. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372 [TBL] [Abstract][Full Text] [Related]
9. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome]. Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966 [TBL] [Abstract][Full Text] [Related]
10. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome. Zeher M; Szodoray P; Gyimesi E; Szondy Z Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867 [TBL] [Abstract][Full Text] [Related]
11. [Cell-mediated immunity in patients with Sjogren's syndrome]. Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation. Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression. Bikker A; van Woerkom JM; Kruize AA; van der Wurff-Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA Ann Rheum Dis; 2012 Dec; 71(12):1934-41. PubMed ID: 22563027 [TBL] [Abstract][Full Text] [Related]
14. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck. Chikamatsu K; Sakakura K; Whiteside TL; Furuya N Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408 [TBL] [Abstract][Full Text] [Related]
15. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations. Moutsopoulos HM; Fauci AS J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308 [TBL] [Abstract][Full Text] [Related]
16. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046 [TBL] [Abstract][Full Text] [Related]
17. [Profiles of type 1 and type 2 T cells in chronic idiopathic thrombocytopenic purpura]. Wang TT; Zhao H; Ren H; Guo JH; Xu MQ; Yang RC; Han ZC Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):669-73. PubMed ID: 16681922 [TBL] [Abstract][Full Text] [Related]
18. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Popa ER; Franssen CF; Limburg PC; Huitema MG; Kallenberg CG; Tervaert JW Arthritis Rheum; 2002 Jul; 46(7):1894-904. PubMed ID: 12124874 [TBL] [Abstract][Full Text] [Related]